These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2728082)

  • 1. Intravenous infusion of enprofylline with an exponentially decreasing drug concentration in acute asthma.
    Arnman K; Willén B; Borgström L; Conradson TB
    Ther Drug Monit; 1989; 11(3):249-52. PubMed ID: 2728082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive bronchodilator effects of terbutaline and enprofylline in asthma.
    Rasmussen JB; Lunell E
    Eur J Clin Pharmacol; 1987; 32(1):23-6. PubMed ID: 3582466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma.
    Boe J; Eriksson G; Ljungholm K
    Ann Allergy; 1987 Aug; 59(2):155-8. PubMed ID: 3619135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
    Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
    Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous enprofylline in the treatment of patients with acute asthma.
    Youngchaiyud P; Charoenratanakul S; Nana A; Wong E; Laxmyr L; Bamberg P
    J Int Med Res; 1990; 18(6):473-82. PubMed ID: 2292329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enprofylline and theophylline for intravenous treatment of acute asthma.
    Haahtela T; Venho K; Eriksson G
    Allergy; 1986 Feb; 41(2):160-2. PubMed ID: 3518528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enprofylline in chronic asthma.
    Chapman BJ; McDonald C; Capewell S; Frame MH; Crompton GK
    Br J Dis Chest; 1988 Oct; 82(4):354-9. PubMed ID: 3076790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous enprofylline in asthma patients.
    Lunell E; Andersson KE; Persson CG; Svedmyr N
    Eur J Respir Dis; 1984 Jan; 65(1):28-34. PubMed ID: 6705855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term xanthine therapy of asthma. Enprofylline and theophylline compared. International Enprofylline Study Group.
    Chapman KR; Ljungholm K; Kallen A
    Chest; 1994 Nov; 106(5):1407-13. PubMed ID: 7956392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect.
    Lunell E; Svedmyr N; Andersson KE; Persson CG
    Eur J Respir Dis; 1983 Jul; 64(5):333-9. PubMed ID: 6309542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous treatment of asthmatic patients with enprofylline and theophylline.
    Laursen LC; Johannesson N; Weeke B
    Eur J Respir Dis; 1984 Oct; 65(7):504-8. PubMed ID: 6386511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of nebulized terbutaline with intravenous enprofylline in patients with acute asthma.
    Ruffin R; Bryant D; Burdon J; Marlin G; Mitchell C; O'Hehir R; Wilson J; Woolcock A; Webb S
    Chest; 1988 Mar; 93(3):510-4. PubMed ID: 3277804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of theophylline and enprofylline on bronchial hyperresponsiveness.
    Koëter GH; Kraan J; Boorsma M; Jonkman JH; van der Mark TW
    Thorax; 1989 Dec; 44(12):1022-6. PubMed ID: 2694418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease.
    Chapman KR; Boucher S; Hyland RH; Day A; Kreisman H; Rivington R; Hodder RV; York EL; Abboud RT; Peters S
    J Allergy Clin Immunol; 1990 Feb; 85(2):514-21. PubMed ID: 2406328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of enprofylline administered intravenously and as a sustained-release tablet at steady state in children with asthma.
    Watson WT; Simons KJ; Simons FE
    J Pediatr; 1988 Apr; 112(4):658-62. PubMed ID: 3351694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
    Laursen LC; Eriksson G; Weeke B
    Respiration; 1986; 50(1):57-61. PubMed ID: 3523664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral enprofylline and theophylline in asthmatic patients.
    Laursen LC; Johannesson N; Søndergaard I; Weeke B
    Eur J Clin Pharmacol; 1984; 26(6):707-9. PubMed ID: 6489410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and some circulatory effects of intravenous and oral enprofylline in healthy volunteers.
    Lunell E; Andersson KE; Persson CG
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):205-11. PubMed ID: 6637510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives.
    Tsunekawa Y; Hasegawa T; Nadai M; Takagi K; Nabeshima T
    J Pharm Pharmacol; 1992 Jul; 44(7):594-9. PubMed ID: 1357141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enprofylline and theophylline on exercise-induced asthma.
    Laursen LC; Johannesson N; Weeke B
    Allergy; 1985 Oct; 40(7):506-9. PubMed ID: 3907395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.